东北制药集团股份有限公司

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — abuse of a dominant market position (辽宁省市场监督管理局 · 市场监管总局发布东北制药集团股份有限公司滥用市场支配地位案行政处罚决定书), from 20 February 2023.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Abuse of a dominant market position.

Details

Company

东北制药集团股份有限公司

Authority

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)

Decision

Abuse of a dominant market position

Grounds and details, as published

辽宁省市场监督管理局 · 市场监管总局发布东北制药集团股份有限公司滥用市场支配地位案行政处罚决定书

From

20 February 2023

Until

—

Status

End date not published

Source

https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_b557d13641f1483383b6c294b6a6aae0.html

Licence

Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)